×
About 3,066 results

ALLMedicine™ Anticoagulation Center

Research & Reviews  1,511 results

Prevalence, outcome and management of patients with SLE and secondary antiphospholipid ...
https://doi.org/10.1093/rheumatology/keaa463
Rheumatology (Oxford, England); Zen M, Loredo Martinez M et. al.

Sep 17th, 2020 - The withdrawal of oral anticoagulation (OAC) in patients with SLE and secondary aPL syndrome (SAPS) who become seronegative has not been clearly investigated to date. Our aim was to evaluate the prevalence of aPL seroconversion and the prognosis o...

Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent ...
https://doi.org/10.1007/s10557-020-07068-9
Cardiovascular Drugs and Therapy; Angelini F, Fortuni F et. al.

Sep 12th, 2020 - Patients with patent foramen ovale (PFO) and cryptogenic ischemic stroke (CS) are at risk for stroke recurrence. The optimal antithrombotic strategy in patients who undergo medical management is still debated. We systematically searched the litera...

Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience.
https://doi.org/10.1016/j.ijcard.2020.09.001
International Journal of Cardiology; Schiavone M, Gasperetti A et. al.

Sep 10th, 2020 - Since the body of evidence addressing the coagulation derangements caused by Coronavirus disease (COVID-19) has been constantly growing, we investigated whether pre-hospitalization oral anticoagulation (OAC) or in-hospital heparin treatment could ...

Efficacy and Safety of Early Systemic Anticoagulation for Preventing Splanchnic Thrombo...
https://doi.org/10.1097/MPA.0000000000001661
Pancreas Zhou J, Zhang H et. al.

Sep 8th, 2020 - Splanchnic venous thrombosis (SVT) is a relevant complication in patients with acute necrotizing pancreatitis. So far, no specific treatment for preventing development of SVT exists, and the effect of systemic anticoagulation (SAC) is unclear. Pat...

Anticoagulant use and the risk of thromboembolism and bleeding in post-operative AF fol...
https://doi.org/10.1016/j.cjca.2020.08.023
The Canadian Journal of Cardiology; Elharram M, Samuel M et. al.

Sep 6th, 2020 - An effective and safe anticoagulation (OAC) strategy for new post-operative AF (POAF) after non-cardiac surgery patients remains unclear. We aimed to determine the association between OAC use and 1) thromboembolic events and 2) major bleeding in p...

see more →

Guidelines  7 results

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.040267
Circulation Schnabel RB,et al

Nov 25th, 2019 - Cardiac thromboembolism attributed to atrial fibrillation (AF) is responsible for up to one-third of ischemic strokes. Stroke may be the first manifestation of previously undetected AF. Given the efficacy of oral anticoagulants in preventing AF-re...

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report
https://journal.chestnet.org/article/S0012-3692(18)32244-X/abstract
Lip, G.,et al.

Nov 27th, 2018 - The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical be.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: opt...
http://www.bloodadvances.org/content/2/22/3257
Witt, D.

Nov 26th, 2018 - Background: Clinicians confront numerous practical issues in optimizing the use of anticoagulants to treat venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support.

Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline...
http://www.learnicu.org/SiteCollectionDocuments/VTE-Prophylaxis-Neuro-Guideline.pdf
Paul Nyquist

Dec 7th, 2015 - The risk of death from venous thromboembolism (VTE) is high in intensive care unit patients with neurological diagnoses. This is due to an increased risk of venous stasis secondary to paralysis as well as an increased prevalence of underlying path.

see more →

Clinicaltrials.gov  1,525 results

Prevalence, outcome and management of patients with SLE and secondary antiphospholipid ...
https://doi.org/10.1093/rheumatology/keaa463
Rheumatology (Oxford, England); Zen M, Loredo Martinez M et. al.

Sep 17th, 2020 - The withdrawal of oral anticoagulation (OAC) in patients with SLE and secondary aPL syndrome (SAPS) who become seronegative has not been clearly investigated to date. Our aim was to evaluate the prevalence of aPL seroconversion and the prognosis o...

Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent ...
https://doi.org/10.1007/s10557-020-07068-9
Cardiovascular Drugs and Therapy; Angelini F, Fortuni F et. al.

Sep 12th, 2020 - Patients with patent foramen ovale (PFO) and cryptogenic ischemic stroke (CS) are at risk for stroke recurrence. The optimal antithrombotic strategy in patients who undergo medical management is still debated. We systematically searched the litera...

Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience.
https://doi.org/10.1016/j.ijcard.2020.09.001
International Journal of Cardiology; Schiavone M, Gasperetti A et. al.

Sep 10th, 2020 - Since the body of evidence addressing the coagulation derangements caused by Coronavirus disease (COVID-19) has been constantly growing, we investigated whether pre-hospitalization oral anticoagulation (OAC) or in-hospital heparin treatment could ...

Efficacy and Safety of Early Systemic Anticoagulation for Preventing Splanchnic Thrombo...
https://doi.org/10.1097/MPA.0000000000001661
Pancreas Zhou J, Zhang H et. al.

Sep 8th, 2020 - Splanchnic venous thrombosis (SVT) is a relevant complication in patients with acute necrotizing pancreatitis. So far, no specific treatment for preventing development of SVT exists, and the effect of systemic anticoagulation (SAC) is unclear. Pat...

Anticoagulant use and the risk of thromboembolism and bleeding in post-operative AF fol...
https://doi.org/10.1016/j.cjca.2020.08.023
The Canadian Journal of Cardiology; Elharram M, Samuel M et. al.

Sep 6th, 2020 - An effective and safe anticoagulation (OAC) strategy for new post-operative AF (POAF) after non-cardiac surgery patients remains unclear. We aimed to determine the association between OAC use and 1) thromboembolic events and 2) major bleeding in p...

see more →

News  23 results

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.040267
Circulation Schnabel RB,et al

Nov 25th, 2019 - Cardiac thromboembolism attributed to atrial fibrillation (AF) is responsible for up to one-third of ischemic strokes. Stroke may be the first manifestation of previously undetected AF. Given the efficacy of oral anticoagulants in preventing AF-re...

Hypoattenuated leaflet thickening often present in bioprosthetic valves
https://www.mdedge.com/cardiology/article/209028/interventional-cardiology-surgery/hypoattenuated-leaflet-thickening-often?channel=236
Doug Brunk

Sep 28th, 2019 - SAN FRANCISCO – The prevalence of hypoattenuated leaflet thickening (HALT) and reduced leaflet motion among patients undergoing transcatheter aortic valve replacement (TAVR) with SAPIEN 3 or surgery was 10% at 30 days and increased to 24% at 1 yea.

Warfarin found to increase adverse outcomes among patients with IPF
https://www.mdedge.com/internalmedicine/article/202001/pulmonology/warfarin-found-increase-adverse-outcomes-among-patients?channel=39313
Michele G. Sullivan

May 31st, 2019 - DALLAS – Warfarin appears to increase the risk of lung transplant or death for patients with fibrotic lung disease who need anticoagulation therapy, Christopher King, MD, said at the American Thoracic Society’s international conference. Michele G.

Anticoagulation shows promise in concurrent lupus nephritis, thrombotic microangiopathy
https://www.mdedge.com/internalmedicine/article/191887/lupus-connective-tissue-diseases/anticoagulation-shows-promise
Caleb Rans

Jan 2nd, 2019 - The use of anticoagulation in patients with comorbid lupus nephritis and thrombotic microangiopathy was linked with a greater rate of clinical response after 12 months of therapy, according to results from a study published in Annals of the Rheuma.

Antithrombotic strategy 1 year after stenting in AF patients leans toward oral anticoagulant alone
https://www.mdedge.com/neurology/article/175969/stroke/antithrombotic-strategy-1-year-after-stenting-af-patients-leans
Jim Kling

Sep 28th, 2018 - SAN DIEGO – In patients with atrial fibrillation and stable coronary artery disease, a randomized trial of oral anticoagulation alone versus an anticoagulant plus a single antiplatelet agent failed to establish noninferiority of the single-agent a.

see more →